Women at Risk for Pregnancy
3
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
3
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Sebela PharmaceuticalsGA - Roswell
2 programs2
VeraCeptPhase 31 trial
VeraCeptPhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Sebela PharmaceuticalsVeraCept
Sebela PharmaceuticalsVeraCept
Clinical Trials (2)
Total enrollment: 1,661 patients across 2 trials
A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)
Start: Dec 2018Est. completion: Aug 202441 patients
Phase 3Completed
Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS
Start: Aug 2018Est. completion: Sep 20271,620 patients
Phase 3Active Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.